Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Shmuel Yaccoby

Concepts (361)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
72
2023
3013
5.220
 Why?
Osteoclasts
18
2015
423
2.610
 Why?
Bone Diseases
7
2014
91
2.180
 Why?
Gene Expression Regulation, Neoplastic
14
2018
853
1.650
 Why?
Osteoblasts
13
2012
478
1.380
 Why?
Neoplasm Proteins
7
2018
328
1.240
 Why?
Mice, SCID
23
2015
178
1.210
 Why?
Osteolysis
6
2013
74
1.180
 Why?
Boronic Acids
13
2013
180
1.160
 Why?
Coculture Techniques
12
2015
142
1.120
 Why?
Bone Marrow
10
2018
354
1.030
 Why?
Bone Marrow Cells
6
2015
188
0.970
 Why?
Bone Neoplasms
3
2014
188
0.930
 Why?
Cell Differentiation
14
2018
667
0.900
 Why?
Bone and Bones
9
2014
492
0.880
 Why?
Pyrazines
12
2013
187
0.870
 Why?
Mice
32
2015
5899
0.860
 Why?
Proteoglycans
6
2008
86
0.830
 Why?
Protein-Tyrosine Kinases
2
2014
92
0.810
 Why?
Cell Proliferation
11
2023
1013
0.760
 Why?
Neoplastic Stem Cells
2
2017
88
0.720
 Why?
Cell Communication
3
2015
74
0.710
 Why?
Animals
35
2016
13485
0.670
 Why?
Intercellular Signaling Peptides and Proteins
4
2010
106
0.670
 Why?
Osteogenesis
5
2012
368
0.660
 Why?
Membrane Glycoproteins
8
2009
239
0.640
 Why?
Bone Resorption
4
2011
300
0.640
 Why?
Cell Movement
6
2014
271
0.620
 Why?
Adipocytes
2
2018
127
0.610
 Why?
Humans
72
2023
52441
0.590
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
9
0.590
 Why?
Antineoplastic Agents
10
2015
1216
0.580
 Why?
Gene Expression
3
2018
618
0.550
 Why?
Gene Expression Regulation, Enzymologic
2
2017
180
0.520
 Why?
Gene Expression Profiling
9
2023
1099
0.520
 Why?
Thalidomide
8
2016
376
0.500
 Why?
Cell Survival
9
2015
598
0.500
 Why?
Protease Inhibitors
4
2010
60
0.490
 Why?
Tumor Microenvironment
2
2015
257
0.480
 Why?
Plasma Cells
8
2012
233
0.470
 Why?
Disease Models, Animal
8
2016
1483
0.460
 Why?
Cytokines
3
2015
622
0.460
 Why?
Cysteine-Rich Protein 61
1
2014
3
0.440
 Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.400
 Why?
Angiogenesis Inhibitors
3
2010
183
0.390
 Why?
Cell Line, Tumor
10
2015
1429
0.390
 Why?
Rabbits
6
2013
370
0.380
 Why?
Mesenchymal Stem Cell Transplantation
1
2012
23
0.380
 Why?
Parathyroid Hormone
4
2010
143
0.360
 Why?
Up-Regulation
3
2013
462
0.360
 Why?
Wnt Proteins
2
2010
102
0.350
 Why?
Signal Transduction
6
2013
1724
0.320
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2016
1020
0.320
 Why?
Transplantation, Heterologous
7
2009
78
0.310
 Why?
Receptor, EphB4
1
2009
5
0.310
 Why?
Ephrin-B2
1
2009
5
0.310
 Why?
Placenta
1
2011
147
0.310
 Why?
Models, Biological
4
2010
735
0.310
 Why?
Fenretinide
1
2009
5
0.310
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2009
6
0.310
 Why?
Dipeptides
1
2009
21
0.300
 Why?
Disease Progression
8
2014
870
0.300
 Why?
Cell Adhesion Molecules
1
2009
89
0.300
 Why?
Bone Development
1
2009
68
0.280
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 13
1
2007
3
0.280
 Why?
Transmembrane Activator and CAML Interactor Protein
1
2007
6
0.280
 Why?
Apoptosis
8
2012
1120
0.280
 Why?
Extracellular Matrix Proteins
1
2008
69
0.280
 Why?
Bone Remodeling
4
2012
151
0.270
 Why?
Prognosis
12
2018
2100
0.260
 Why?
Recombinant Fusion Proteins
1
2007
177
0.260
 Why?
Melphalan
3
2016
176
0.260
 Why?
Tumor Cells, Cultured
8
2013
441
0.250
 Why?
Immunohistochemistry
5
2015
977
0.250
 Why?
Neoplasm Recurrence, Local
3
2023
639
0.250
 Why?
Antibodies
1
2006
144
0.250
 Why?
Serine Endopeptidases
1
2006
50
0.240
 Why?
Cell Division
6
2004
288
0.240
 Why?
RNA, Small Interfering
4
2013
217
0.240
 Why?
Antigens, Neoplasm
1
2006
145
0.230
 Why?
Severe Combined Immunodeficiency
1
2005
11
0.230
 Why?
Neovascularization, Pathologic
4
2009
158
0.230
 Why?
Alkaline Phosphatase
6
2017
92
0.220
 Why?
Flow Cytometry
6
2015
396
0.220
 Why?
Syndecan-1
6
2007
73
0.220
 Why?
NF-kappa B
4
2013
326
0.210
 Why?
Hematopoietic Stem Cells
3
2012
180
0.210
 Why?
Receptors, CXCR4
2
2014
31
0.210
 Why?
Gene Knockdown Techniques
2
2014
110
0.200
 Why?
Bone Density
3
2010
396
0.200
 Why?
Positron-Emission Tomography
2
2017
297
0.200
 Why?
Translocation, Genetic
2
2021
266
0.200
 Why?
Killer Cells, Natural
2
2015
111
0.200
 Why?
Transcription Factors
2
2023
570
0.190
 Why?
Stromal Cells
1
2003
76
0.190
 Why?
Female
21
2018
28277
0.190
 Why?
Neoplasm Transplantation
3
2014
86
0.190
 Why?
Immunophenotyping
2
2015
115
0.180
 Why?
T-Lymphocytes
2
2015
318
0.180
 Why?
Immunotherapy, Adoptive
2
2015
156
0.180
 Why?
Cell Line
2
2015
1020
0.180
 Why?
Immunoglobulin Light Chains
2
2015
90
0.180
 Why?
Epigenomics
1
2021
75
0.180
 Why?
Antibodies, Monoclonal
4
2016
475
0.170
 Why?
Bone Transplantation
4
2010
42
0.170
 Why?
Decorin
2
2012
7
0.170
 Why?
Oligonucleotide Array Sequence Analysis
4
2015
412
0.160
 Why?
Cells, Cultured
4
2013
1583
0.160
 Why?
Neoplasm Metastasis
2
2014
235
0.160
 Why?
Syndecans
5
2006
37
0.150
 Why?
Drug Resistance, Neoplasm
2
2015
336
0.150
 Why?
Genes, myc
1
2019
39
0.150
 Why?
Cell Adhesion
2
2014
162
0.150
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2015
580
0.150
 Why?
Mice, Transgenic
4
2007
566
0.140
 Why?
Male
17
2018
26874
0.140
 Why?
Risk Factors
5
2018
3971
0.140
 Why?
Cyclin-Dependent Kinases
2
2015
26
0.140
 Why?
Hexokinase
1
2017
16
0.130
 Why?
Diffusion Magnetic Resonance Imaging
1
2018
131
0.130
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2018
123
0.130
 Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
 Why?
Chromosome Aberrations
3
2016
295
0.130
 Why?
Tumor Suppressor Protein p53
2
2017
224
0.130
 Why?
Disease-Free Survival
5
2018
461
0.130
 Why?
Calcification, Physiologic
1
2017
42
0.130
 Why?
Proteasome Inhibitors
2
2016
101
0.130
 Why?
Pelvis
1
2017
65
0.130
 Why?
Chromosome Deletion
1
2017
138
0.130
 Why?
Stem Cells
2
2009
186
0.120
 Why?
Biopsy
2
2018
594
0.120
 Why?
Neoplasm, Residual
1
2017
169
0.120
 Why?
Neoplasms, Experimental
2
2007
111
0.120
 Why?
Fluorodeoxyglucose F18
1
2017
181
0.120
 Why?
Base Sequence
2
2008
632
0.120
 Why?
Recurrence
3
2014
680
0.120
 Why?
Pyridinium Compounds
1
2015
20
0.120
 Why?
Homologous Recombination
1
2015
44
0.120
 Why?
Endothelial Cells
2
2009
283
0.120
 Why?
Xenograft Model Antitumor Assays
3
2015
218
0.120
 Why?
Benzimidazoles
1
2015
50
0.120
 Why?
Peptide Nucleic Acids
1
2015
18
0.120
 Why?
Rad51 Recombinase
1
2015
28
0.120
 Why?
Genes, Neoplasm
1
2015
31
0.120
 Why?
Aged
11
2017
10242
0.110
 Why?
Bromodeoxyuridine
2
2005
17
0.110
 Why?
Immunologic Factors
1
2016
114
0.110
 Why?
Time Factors
7
2017
2987
0.110
 Why?
Genomic Instability
1
2015
87
0.110
 Why?
Diphosphonates
2
2008
92
0.110
 Why?
Antigens, CD
1
2015
213
0.110
 Why?
Asymptomatic Diseases
1
2014
38
0.110
 Why?
Carrier Proteins
4
2008
312
0.110
 Why?
Immunotherapy
1
2016
251
0.110
 Why?
Proteome
1
2015
175
0.110
 Why?
Interleukin-6
2
2005
271
0.100
 Why?
Nicotinamide Mononucleotide
1
2013
4
0.100
 Why?
Acrylamides
1
2013
9
0.100
 Why?
Antigens, CD19
2
2005
27
0.100
 Why?
Poly(ADP-ribose) Polymerases
1
2013
30
0.100
 Why?
Niacinamide
1
2013
24
0.100
 Why?
Enzyme Induction
1
2013
78
0.100
 Why?
Amides
1
2013
36
0.100
 Why?
NAD
1
2013
46
0.100
 Why?
Enzyme Inhibitors
2
2013
378
0.100
 Why?
Sirtuin 1
1
2013
29
0.100
 Why?
Nitriles
1
2013
51
0.100
 Why?
Proteomics
1
2015
332
0.100
 Why?
Tumor Burden
2
2010
132
0.100
 Why?
Chemokine CXCL12
1
2013
35
0.100
 Why?
beta Catenin
1
2013
105
0.100
 Why?
Oligopeptides
1
2013
94
0.100
 Why?
Magnetic Resonance Imaging
2
2012
1507
0.100
 Why?
Middle Aged
11
2018
13133
0.100
 Why?
Leukemia
1
2013
67
0.100
 Why?
Myelodysplastic Syndromes
1
2013
86
0.100
 Why?
Injections, Intravenous
1
2012
130
0.090
 Why?
Proto-Oncogene Proteins c-jun
2
2009
76
0.090
 Why?
Piperidines
1
2013
99
0.090
 Why?
Cytotoxicity, Immunologic
1
2012
55
0.090
 Why?
Myeloma Proteins
2
2004
26
0.090
 Why?
Remission Induction
1
2012
218
0.090
 Why?
Neoplasm Staging
3
2015
768
0.090
 Why?
RNA, Messenger
3
2015
1134
0.090
 Why?
Renal Insufficiency
1
2012
109
0.090
 Why?
Anti-Inflammatory Agents
1
2012
166
0.090
 Why?
Glycoproteins
2
2001
123
0.080
 Why?
Lymph Nodes
1
2012
253
0.080
 Why?
beta 2-Microglobulin
2
2007
39
0.080
 Why?
JNK Mitogen-Activated Protein Kinases
2
2007
71
0.080
 Why?
Early Growth Response Protein 1
1
2009
34
0.080
 Why?
Dexamethasone
3
2007
434
0.080
 Why?
Myocardium
1
2012
471
0.080
 Why?
Sphingosine
1
2009
33
0.080
 Why?
Organoids
1
2009
35
0.070
 Why?
Prospective Studies
5
2016
2433
0.070
 Why?
Drug Screening Assays, Antitumor
1
2009
135
0.070
 Why?
Caspases
1
2009
101
0.070
 Why?
Lysophospholipids
1
2009
68
0.070
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
94
0.070
 Why?
Leukocytes, Mononuclear
1
2009
122
0.070
 Why?
Enzyme Activation
1
2009
269
0.070
 Why?
Glucuronidase
2
2007
47
0.070
 Why?
Lentivirus
1
2008
17
0.070
 Why?
Wnt3 Protein
1
2008
7
0.070
 Why?
Ellipticines
1
2008
2
0.070
 Why?
Wnt3A Protein
1
2008
12
0.070
 Why?
Bone Density Conservation Agents
1
2009
75
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
68
0.070
 Why?
B-Cell Activating Factor
1
2007
3
0.070
 Why?
Precancerous Conditions
1
2008
87
0.070
 Why?
Cytological Techniques
1
2007
13
0.070
 Why?
Diploidy
1
2007
25
0.070
 Why?
Genetic Vectors
1
2008
128
0.070
 Why?
RNA Interference
1
2008
183
0.070
 Why?
Phosphorylation
1
2009
536
0.070
 Why?
Karyotyping
1
2007
77
0.070
 Why?
Heparan Sulfate Proteoglycans
1
2007
12
0.070
 Why?
Hematopoietic Stem Cell Transplantation
1
2012
600
0.070
 Why?
Kidney
1
2012
716
0.070
 Why?
Receptor Activator of Nuclear Factor-kappa B
2
2004
33
0.070
 Why?
Reactive Oxygen Species
1
2009
415
0.070
 Why?
Mice, Inbred C57BL
1
2012
1888
0.060
 Why?
Models, Animal
1
2007
230
0.060
 Why?
Phenotype
2
2009
792
0.060
 Why?
Treatment Outcome
6
2017
5508
0.060
 Why?
Immunosuppressive Agents
1
2008
248
0.060
 Why?
Gelatinases
1
2006
32
0.060
 Why?
Risk Assessment
3
2018
1349
0.060
 Why?
Endopeptidases
1
2006
62
0.060
 Why?
Survival Analysis
2
2018
656
0.060
 Why?
Antigens, CD34
1
2005
73
0.060
 Why?
Adult
6
2018
14205
0.060
 Why?
RANK Ligand
2
2004
188
0.060
 Why?
Hematologic Neoplasms
1
2006
101
0.060
 Why?
Fetal Tissue Transplantation
1
2005
12
0.060
 Why?
Molecular Sequence Data
1
2006
778
0.060
 Why?
Metaphase
2
2016
47
0.060
 Why?
Annexin A5
1
2004
14
0.050
 Why?
Endothelium, Vascular
1
2006
263
0.050
 Why?
Culture Media, Conditioned
1
2004
46
0.050
 Why?
Survival Rate
2
2018
944
0.050
 Why?
Clinical Trials as Topic
3
2016
461
0.050
 Why?
Phagocytosis
1
2004
54
0.050
 Why?
Membrane Proteins
1
2006
344
0.050
 Why?
Polymerase Chain Reaction
1
2005
458
0.050
 Why?
Pregnancy
1
2011
2642
0.050
 Why?
Endothelial Growth Factors
1
2002
11
0.050
 Why?
Vascular Endothelial Growth Factors
1
2002
15
0.050
 Why?
Lymphokines
1
2002
20
0.050
 Why?
Biotransformation
1
2002
83
0.050
 Why?
Oxidative Stress
1
2007
805
0.050
 Why?
Blotting, Western
2
2015
587
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2002
186
0.050
 Why?
Oncogenes
1
2021
61
0.040
 Why?
Combined Modality Therapy
2
2016
641
0.040
 Why?
Imidazoles
1
2002
114
0.040
 Why?
Polycomb Repressive Complex 2
1
2021
47
0.040
 Why?
Chromatin
1
2021
143
0.040
 Why?
Cell Polarity
1
2000
15
0.040
 Why?
Liver Transplantation
1
2002
171
0.040
 Why?
Cell Transplantation
1
1999
3
0.040
 Why?
Mice, Inbred ICR
1
1999
25
0.040
 Why?
Histones
1
2021
315
0.040
 Why?
Cell Membrane
1
2000
238
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
12
0.040
 Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
1365
0.040
 Why?
Osteoprotegerin
3
2006
53
0.040
 Why?
Radiation Chimera
1
1998
4
0.040
 Why?
Multivariate Analysis
2
2012
601
0.040
 Why?
Radiography
2
2012
469
0.040
 Why?
Clone Cells
1
1998
76
0.040
 Why?
Aged, 80 and over
2
2017
3449
0.040
 Why?
DNA-Binding Proteins
1
2021
423
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
262
0.040
 Why?
Tomography, X-Ray Computed
2
2017
1140
0.030
 Why?
False Positive Reactions
1
2017
64
0.030
 Why?
Liver
1
2002
1150
0.030
 Why?
Imaging, Three-Dimensional
1
2017
150
0.030
 Why?
Indolizines
1
2015
5
0.030
 Why?
Cyclic N-Oxides
1
2015
12
0.030
 Why?
Drug Synergism
1
2015
147
0.030
 Why?
S Phase
1
2015
20
0.030
 Why?
Genes, BRCA1
1
2015
18
0.030
 Why?
Transcriptome
1
2018
357
0.030
 Why?
Follow-Up Studies
2
2013
2294
0.030
 Why?
Predictive Value of Tests
2
2007
938
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
182
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
234
0.030
 Why?
Transcription, Genetic
1
2015
375
0.030
 Why?
DNA Damage
1
2015
298
0.030
 Why?
Transfection
2
2004
365
0.020
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
7
0.020
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
8
0.020
 Why?
Interleukin-2
1
2012
69
0.020
 Why?
Acute Disease
1
2013
384
0.020
 Why?
Mice, Inbred NOD
1
2012
91
0.020
 Why?
Immunoenzyme Techniques
1
2012
134
0.020
 Why?
Glomerular Filtration Rate
1
2012
126
0.020
 Why?
Creatinine
1
2012
156
0.020
 Why?
Lymphocyte Activation
1
2012
161
0.020
 Why?
Receptors, Tumor Necrosis Factor
2
2001
36
0.020
 Why?
C-Reactive Protein
1
2012
151
0.020
 Why?
Receptors, Cytoplasmic and Nuclear
2
2001
67
0.020
 Why?
Proportional Hazards Models
1
2012
446
0.020
 Why?
Radiation-Sensitizing Agents
1
2010
50
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2009
20
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
11
0.020
 Why?
Incidence
1
2013
1096
0.020
 Why?
Protein Transport
1
2010
172
0.020
 Why?
Microtubule-Associated Proteins
1
2009
61
0.020
 Why?
Peptides
1
2010
239
0.020
 Why?
Down-Regulation
1
2009
348
0.020
 Why?
CDC2-CDC28 Kinases
1
2008
11
0.020
 Why?
Salvage Therapy
1
2008
137
0.020
 Why?
Protein Binding
1
2009
673
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2009
230
0.020
 Why?
Proteins
1
2010
353
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
56
0.020
 Why?
Cytogenetic Analysis
1
2007
79
0.020
 Why?
Cell Cycle
1
2008
236
0.020
 Why?
Phospholipase C gamma
1
2006
4
0.020
 Why?
Caspase 9
1
2006
13
0.020
 Why?
Chi-Square Distribution
1
2007
292
0.020
 Why?
Retrospective Studies
2
2012
6694
0.020
 Why?
Mitogen-Activated Protein Kinase 3
1
2006
47
0.020
 Why?
Bone Marrow Transplantation
1
2007
110
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
src-Family Kinases
1
2006
50
0.020
 Why?
Case-Control Studies
1
2009
1202
0.020
 Why?
Chromosome Mapping
1
2006
149
0.020
 Why?
Mice, Inbred BALB C
1
2006
304
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2006
168
0.010
 Why?
Cluster Analysis
1
2006
236
0.010
 Why?
Phosphatidylinositol 3-Kinases
1
2006
147
0.010
 Why?
Kaplan-Meier Estimate
1
2007
485
0.010
 Why?
Data Interpretation, Statistical
1
2006
166
0.010
 Why?
Transplantation, Autologous
1
2007
479
0.010
 Why?
Logistic Models
1
2007
930
0.010
 Why?
DNA, Complementary
1
2004
129
0.010
 Why?
Young Adult
1
2013
4346
0.010
 Why?
Recombinant Proteins
1
2004
490
0.010
 Why?
Randomized Controlled Trials as Topic
1
2005
625
0.010
 Why?
Solubility
1
2002
81
0.010
 Why?
Leukemia, Plasma Cell
1
2002
33
0.010
 Why?
Acid Phosphatase
1
2001
12
0.010
 Why?
Protein Structure, Tertiary
1
2002
260
0.010
 Why?
Adolescent
1
2013
6713
0.010
 Why?
Neoplasm Invasiveness
1
2002
278
0.010
 Why?
Hodgkin Disease
1
2001
45
0.010
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2001
58
0.010
 Why?
Isoenzymes
1
2001
171
0.010
 Why?
Reference Values
1
2001
316
0.010
 Why?
Paraproteinemias
1
2001
72
0.010
 Why?
LDL-Receptor Related Protein-Associated Protein
1
2000
1
0.010
 Why?
Hepatocyte Growth Factor
1
2000
11
0.010
 Why?
Intercellular Adhesion Molecule-1
1
2000
59
0.010
 Why?
Epithelial Cells
1
2000
217
0.010
 Why?
Yaccoby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (361) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department